Susan Tsai

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Mandana Kamgar, G Aaron Hobbes, Raven Davidson

|Dec 23, 2023
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

Saryleine de Ortiz de Choudens, Alexis Visotcky, Anjishnu Banerjee

|Mar 24, 2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

Sam Z Thalji, Mohammed Aldakkak, Kathleen K Christians

|Dec 08, 2022
Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

Sam Z Thalji, Cecilia G Ethun, Susan Tsai

|Dec 13, 2021
Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer.

Susan Tsai, Douglas B Evans

|Apr 08, 2021
Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective.

Erin P Ward, Douglas B Evans, Susan Tsai

Pageof 1

Frequent Collaborators

3 joint publications

Sam Z Thalji

2 joint publications

Callisia N Clarke

2 joint publications

Mandana Kamgar

2 joint publications

William Hall